医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

Agilent to Support Korea Doping Control Center

2018年02月09日 AM01:00
このエントリーをはてなブックマークに追加


 

SANTA CLARA, Calif.

Agilent Technologies Inc. (NYSE:A) today announced it will collaborate with the Doping Control Center in Seoul, South Korea, to ensure that athletes from around the world are quickly and accurately tested to determine whether any have been using banned substances to enhance their performances.

Agilent has been a major supplier of analytical instruments to the center since 1984. During events this winter, the company will have certified engineers on standby around the clock to ensure the highest level of service. The center is expected to run 4,000 urine tests during multiple work shifts.

“To ensure the most reliable performance of instruments during this critical drug-testing period, strong and timely support from Agilent is essential,” said Oh-Seung Kwon, Ph.D., director and principal research scientist at the Doping Control Center.

Established by the Korea Institute of Science and Technology in 1984, the center is an accredited lab of the World Anti-Doping Agency.

Agilent systems are highly automated to provide rapid test results at a glance, enabling the use of screening methods for identifying banned substances in sport.

In addition to providing advanced instrumentation, Agilent also helps labs develop further methods for detecting banned substances, trains investigators, and provides technical support and maintenance of the instruments.

“We are pleased that Agilent can provide emergency support resources and systems to protect the athletes’ health and induce fair competition,” said Jong-Gon Kim, country service business manager at Agilent Technologies Korea.

About Agilent Technologies

Agilent Technologies Inc. (NYSE: A) is a global leader in life sciences, diagnostics and applied chemical markets. With more than 50 years of insight and innovation, Agilent instruments, software, services, solutions, and people provide trusted answers to its customers’ most challenging questions. The company generated revenues of $4.47 billion in fiscal 2017 and employs 13,500 people worldwide. Information about Agilent is available at www.agilent.com.

View source version on businesswire.com: http://www.businesswire.com/news/home/20180208005893/en/

CONTACT

Agilent Technologies
Victoria Wadsworth-Hansen, +1 408-553-2005 or
+45 2933 6980
victoria.wadsworth-hansen@agilent.com

Related Posts Plugin for WordPress, Blogger...

同じカテゴリーの記事 

  • 内布拉斯加大学医学中心和阿南达宣布,FDA批准了一项治疗创伤后应激障碍(PTSD)的研究性新药的临床试验
  • Emendo Biotherapeutics’ next generation CRISPR gene editing technologies achieve breakthrough results with allele-specific approach for ELANE-related Severe Congenital Neutropenia as presented at ASGCT Annual Meeting
  • Morinaga Milk Obtains the Registration of “New Food Ingredient” in China for Use of Its Probiotic Bifidobacterium longum BB536 in Infant and Toddler Foods
  • MSITEK Sponsors a Hospice IT and Digital Project in India as Part of CSR (Corporate Social Responsibility) Initiatives
  • XlearがDr. Ferrer BioPharmaと提携し、以前にも増して優れたユーザー体験を鼻腔衛生にもたらす